September 16, 2019
  • September 16, 2019
Breaking News
  • Home
  • Business
  • Top Loser in Spotlight: Melinta Therapeutics, Inc. (MLNT)

Top Loser in Spotlight: Melinta Therapeutics, Inc. (MLNT)

By on July 8, 2019 0

The insider ownership percentage is the key indicator, can be used by investors, to measure the outlook of senior management has on their company. Insider ownership for the MLNT is 7.28%. Institutional ownership refers to the ownership stake in a company that is held by large financial organizations, pension funds or endowments. The Institutional ownership for the MLNT is 28.10%.



Institutional transactions is the amount of a Melinta Therapeutics, Inc. (NASDAQ:MLNT)’s available stock owned by mutual or pension funds, insurance companies, investment firms, private foundations, endowments or other large entities that actually manage the funds on the behalf of others, so its an interesting element for the traders to note it, and the Institutional ownership for the MLNT is -53.22%.

A Healthcare sector firm, Melinta Therapeutics, Inc. (NASDAQ:MLNT) stock fell -9.13% on Sunday and when day-trade ended the stock finally concluded at $7.17 and number of shares that changed hands during the day are 2.22 Million. The number of shares MLNT stock currently held by all its shareholders are 11.33 and floated shares, the number of shares are available for trading in an open market on last trading day are 10.96. The average volume of shares for 3 months is 2395.40 and MLNT stock value has moved between $1.62 – 34.14 in last one year.

The Melinta Therapeutics, Inc. (NASDAQ:MLNT)’s latest earnings date is 8/8/2019. The Gross margin is the difference between the revenue and the cost of goods sold (COGS), divided by revenue. In other words, Gross Margin is a percentage value, while Gross Profit is a monetary value. The valuable gross margin for Melinta Therapeutics, Inc. (NASDAQ:MLNT) is 57.40% and the stock has gained 80.90% in 2019 to date.
[finviz ticker=MLNT]
Melinta Therapeutics, Inc. (NASDAQ:MLNT)’s monthly stock performance is 213.10%, the quarterly performance is 73.19%, the half year performance is calculated as 37.88%. The yearly performance of MLNT is -77.94%.

The higher the volatility, the riskier the security. For example, when the stock market rises and falls more than one percent over a sustained period of time, it is called a “volatile” market, if the stock price stays relatively stable, the security has low volatility. The Melinta Therapeutics, Inc. (NASDAQ:MLNT) weekly volatility is measured as 15.00% and monthly volatility measured as 19.85%.

Return on assets (ROA) is a main indicator of how profitable a company is relative to its total assets. MLNT return on assets is -32.30%, the return on equity (ROE) of the Melinta Therapeutics, Inc. (NASDAQ:MLNT) is -71.60%, while the most important return on investment is calculates as a percentage and is typically used for personal financial decisions, and MLNT return on investment is -51.80%.

The price to sales ratio is 0.85, and price to book ratio is 0.46, price to cash per share ration is 0.69.

Analysts mean target price for Melinta Therapeutics, Inc. (NASDAQ:MLNT) is $11.00 while analysts mean recommendation is 2.70. The current share price indicates that stock is -79.22% away from its one year high and is moving 342.59% ahead of its 52-week low. MLNT’s distance from 20 day simple moving average is 67.13% and distance from 50-Day simple moving average is 88.15%.






Leave a comment